Following Decision No.85/QD-SGDHN dated February 22, 2024, HNX announces the continued trading suspension of HLA stock as follows:
- Reason for trading suspension: the company did not disclose the Audited Financial Statement for 2023 for over 45 days as prescribed by the regulations (fiscal years from October 01 to September 31 of the following year)
- Reason for continued trading suspension: The company did not have nay remedy to overcome the reason for trading restriction according to Point d Section 1 Article 46 of Law on Securities
- Applicable law(s): Points e Section 1 Article 36 of the Regulations attached to Decision No.34/QD-HDTV dated November 16, 2022 of the Vietnam Stock Exchange.
This decision replaces Decision No.1276/QD-SGDHN dated 07/12/2023 for putting HLA under trading suspension.
Within 15 days from the date the stock is under continued trading suspension as prescribed in Article 1 of this Decision, HLA must send a document to the HNX to explain the cause and provide a remedy.